Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial

CP24

13 May 2021 0 shares 4 views

Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial

CP24

Published 13 May 2021

A homegrown mRNA vaccine for COVID-19 shows promising results in its first small trial and its maker is hoping to test it directly against the vaccine from Pfizer-BioNTech.

Full Article

Dow adds more than 300 points to record close, Nasdaq turns positive in afternoon jump

4:20pm: PayPal shares pop on earnings beat Traders stepped on the gas in the final hours, propeling the Dow 318 points higher, a..

Proactive Investors 06 May 2021

Wall Street mixed at midday despite better than expected jobs data

12:20pm: Pharmaceutical stocks fall The Dow was up 162 points, 0.5%, to 34,393 at midday. The Nasdaq was ticked down 7 points to..

Proactive Investors 06 May 2021

Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial

Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial

You might like

Related news coverage

Dow adds more than 300 points to record close, Nasdaq turns positive in afternoon jump

Wall Street mixed at midday despite better than expected jobs data

Advertisement